Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Digital Pathology Software for Remote Use

Proscia
By Author Proscia | May 7, 2020

Proscia has made its Concentriq Dx digital pathology software available for use in reviewing and reporting of digital pathology slides in the United States. In Europe, Concentriq Dx is CE-marked for use in primary diagnosis. In the United States, the software will support the need for remote pathology brought about by the COVID-19 pandemic. The company’s announcement comes as FDA has issued new guidance aimed at expanding the availability of remote digital pathology devices.

Our website uses cookies. By using this site, you agree to its use of cookies.